Actinium Pharmaceuticals
ATNM
$9.63
Share price
-0.62%
Change (1 day)
7.60%
Change (1 year)
Categories
Actinium Pharmaceuticals (ATNM) - Cash on Hand
Cash on Hand as of March 2024 : $84.05 M
According to Actinium Pharmaceuticals's latest financial reports the company has $84.05 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Actinium Pharmaceuticals - Cash on Hand chart (from 2006 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.10 B | 39.93% |
| 2021-12-31 | $77.82 M | 22.45% |
| 2020-12-31 | $63.56 M | 586.84% |
| 2019-12-31 | $9.25 M | -32.32% |
| 2018-12-31 | $13.67 M | -21.42% |
| 2017-12-31 | $17.39 M | -15.2% |
| 2016-12-31 | $20.51 M | -19.98% |
| 2015-12-31 | $25.64 M | 281.7% |
| 2014-12-31 | $6.71 M | 21.29% |
| 2013-12-31 | $5.53 M | -1.42% |
| 2012-12-31 | $5.61 M | -1.49% |
| 2011-12-31 | $5.7 M | 3802432% |
| 2010-12-31 | $0 M | -92.93% |
| 2009-12-31 | $0 M | -4.33% |
| 2008-12-31 | $0 M | -4.15% |
| 2007-12-31 | $0 M | 396.57% |
| 2006-12-31 | $0 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | $20.13 M | -76.04% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.28 B | 240.48% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.04 B | 1,145.08% | 🇺🇸 USA |